NICHOLAS RYAN CHASSE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner LINCOLN, RI NPI 1063991024

General Payments — all program years on this page

$3,403.08

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 169
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $420.63 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $420.6321

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $931.5645
2022 $1,549.3176
2023 $501.5827
2024 $420.6321

Records — PY2024 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086285990 Bayer Healthcare Pharmaceuticals Inc. $17.56 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100234912 Novo Nordisk Inc $22.32 11/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100541072 Novo Nordisk Inc $20.96 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100559695 Novo Nordisk Inc $19.88 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100636175 Novo Nordisk Inc $21.95 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104213745 AstraZeneca Pharmaceuticals LP $24.60 10/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104339144 AstraZeneca Pharmaceuticals LP $16.26 10/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104362457 AstraZeneca Pharmaceuticals LP $31.05 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105392936 AstraZeneca Pharmaceuticals LP $22.89 11/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106905420 ABBVIE INC. $20.78 01/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115916997 GlaxoSmithKline, LLC. $14.57 11/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116231405 GlaxoSmithKline, LLC. $17.18 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116293735 GlaxoSmithKline, LLC. $16.19 02/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116328872 GlaxoSmithKline, LLC. $23.07 10/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116404999 GlaxoSmithKline, LLC. $18.47 11/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1117524729 Amgen Inc. $16.26 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147316858 Mylan Specialty L.P. $23.99 10/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148141042 Inspire Medical Systems, Inc. $22.53 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148141046 Inspire Medical Systems, Inc. $17.29 10/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148141051 Inspire Medical Systems, Inc. $14.37 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1152302873 Lucid Diagnostics Inc. $18.46 10/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.